Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Total Non-Current Liabilities (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Total Non-Current Liabilities data on record, last reported at $2.5 billion in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 3.43% year-over-year to $2.5 billion; the TTM value through Dec 2025 reached $2.5 billion, down 3.43%, while the annual FY2025 figure was $2.5 billion, 3.43% down from the prior year.
  • Total Non-Current Liabilities reached $2.5 billion in Q4 2025 per AHCO's latest filing, up from $2.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $3.1 billion in Q3 2021 and bottomed at $2.5 billion in Q2 2021.
  • Average Total Non-Current Liabilities over 5 years is $2.8 billion, with a median of $2.7 billion recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: soared 264.99% in 2021, then fell 9.38% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $3.1 billion in 2021, then decreased by 3.29% to $3.0 billion in 2022, then fell by 9.38% to $2.7 billion in 2023, then dropped by 3.76% to $2.6 billion in 2024, then fell by 3.43% to $2.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $2.5 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.5 billion in Q2 2025.